Skip to content

Enlightenment in a Pill—Testing the Efficacy of Psilocybin

James I. Hudson, Harrison G. Pope

JAMA Psychiatry March 18, 2026 DOI: 10.1001/jamapsychiatry.2026.0070 via OpenAlex

Summary

AI-generated from the abstract

A guided psychedelic experience with psilocybin may treat refractory depression by inducing a mystical experience, rather than through a simple biological drug effect. The text suggests that the therapeutic benefit could stem from the profound, transformative nature of the experience, as conceptualized by William James.

Study at a glance

Characteristics Commentary Peer reviewed
Population Refractory depression
Citations 1
Key finding A guided psychedelic experience with psilocybin may treat refractory depression by inducing a mystical experience.

Abstract

Can a guided psychedelic experience with psilocybin successfully treat refractory depression? In other words, setting aside any simple direct biological drug effect, can psychedelic-assisted psychotherapy1 alleviate suffering via what William James would call a mystical experience?2

Comments

No comments yet.

Log in to comment